GREENLAND MINES LTD Payments for Repurchase of Initial Public Offering
GREENLAND MINES LTD (GRML) reported Payments for Repurchase of Initial Public Offering of $587.72 thousand for the 12-month period ending 2022-12-31, per its 10-K/A filed 2023-10-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfInitialPublicOffering · last filed 2023-10-18
- GREENLAND MINES LTD payments for repurchase of initial public offering for the quarter ending 2022-12-31 was $0.00.
- GREENLAND MINES LTD payments for repurchase of initial public offering for the quarter ending 2022-09-30 was $0.00.
- GREENLAND MINES LTD payments for repurchase of initial public offering for the quarter ending 2022-06-30 was -$1.91M.
- GREENLAND MINES LTD payments for repurchase of initial public offering for the quarter ending 2022-03-31 was $2.50M.
- GREENLAND MINES LTD payments for repurchase of initial public offering for fiscal 2022 was $587.72K.
| Period end | Payments for Repurchase of Initial Public Offering 3 month | Payments for Repurchase of Initial Public Offering 6 month | Payments for Repurchase of Initial Public Offering 9 month | Payments for Repurchase of Initial Public Offering 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-10-18 | $0.00 derived: sum of 2 quarters · filed 2023-10-18 | -$1.91M derived: sum of 3 quarters · filed 2023-10-18 | $587.72K 10-K/A · filed 2023-10-18 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.91M derived: sum of 2 quarters · filed 2022-11-14 | $587.72K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $587.72K 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | $2.50M 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |